| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35K | — | -68.0% |
| Cost of Revenue | $7K | — | -85.0% |
| SG&A Expense | $2.9M | — | +58.9% |
| Operating Income | -$7.7M | — | -237.9% |
| Net Income | -$7.7M | — | -215.6% |
| EPS (Basic) | -$0.36 | — | -5.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.9M | -35.8% | +124.3% |
| Accounts Receivable | $659K | +1952.7% | +1002.0% |
| Current Assets | $37.6M | -12.1% | +978.4% |
| Total Assets | $45.2M | -14.5% | +670.6% |
| Current Liabilities | $4.2M | -0.9% | -8.3% |
| Total Liabilities | $5.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $21K | — | — |
| -17.7% |
| Stockholders' Equity | $40.3M | -15.6% | — |